2008 – present. CEO & President, Elements Behavioral Health and Promises Treatment Centers
A private equity backed company providing treatment solutions for individuals with emotional and addictive disorders. Treatment centers are Promises Treatment Centers, The Ranch at Piney River, The Recovery Place, and The Sexual Recovery Institute.
2006 President, Eating Disorders Ventures LLC
A joint venture with Aspen Education Group, Inc., Cerritos, California. Development and manage Eating Disorder treatment programs. Acquired by CRC Heath Group 11/06.
2000 – 2005 Chief Medical Officer, National Director of Clinical Research, Comprehensive NeuroScience, Inc., White Plains, NY.
Supervised all aspects of clinical trials programs specializing in disorders of the central nervous and clinical pharmacology. Responsibilities included oversight of protocol design, feasibility, regulatory compliance, safety. Oversight of 70 bed Phase I unit and 9 Phase II-IV sites.
1994 – 1999 Principal Investigator
Clinical trials program focused on central nervous system diseases, in Cerritos, CA. Key accomplishments: Successful enrollment, retention and separation from placebo in numerous pivotal trials of antipsychotic medications, mood stabilizers, antidepressants, cognitive and sedative hypnotic medications.
1998 – 2001 Senior Vice President, Clinical Services, Aspen Education Group, Cerritos, CA
Built and managed the operations of the Community Services Division, the largest privately owned network of publicly funded mental health centers in California, specializing in the treatment of high risk youth.
1993 – 2001 President and Medical Director, College Health IPA, Cerritos, CA
A managed behavioral health group practice. Wrote the utilization/managment guidelines and supervised clincal operations. Directly surpervised credentialling and care management. Developed financial models used to negotiate and manage capatiated and risk contracts for behavioral services. Developed a statewide provider network in California. In addition successfully implemented instensive rehabiliation programs and substance abuse treatment programs contracted to County Mental Health Agencies.
1982 – 1999 Private Practice Experience
Inpatient and outpatient treatment of patients with mood, anxiety and thought disorders. Developed and supervised ambulatory detoxification and substance abuse treatment programs. Extensive experience with treatment resistant depression including the use of electroconvulsive therapy.
1993 – 1999 Senior Medical, Director, College Hospital, Cerritos, CA
Responsible for professional affairs, regulatory compliance and managed care contracting. Directly supervised credentialing, peer review and professional conduct, development of policies and procedures, and survey preparation.
1987 – 1993 Medical, Director, Los Altos Hospital and Mental Health Center, Long Beach, CA
Responsible for medical affairs and regulatory compliance. Key Accomplishments: Awarded Best New Hospital recognition by national hospital corporation. Implemented specialized programs for Panic disorder and Post-traumatic stress disorder. Authored book on adult victims of sexual abuse. Implemented a successful electroconvulsive therapy program despite a hostile regulatory environment.
1983 – 1987 Chief, Inpatient Unit, Clinical Psychobiology Branch, National Institute of Mental Health Bethesda, MD
Supervised all research trials conducted on an inpatient mental health unit at the Clinical Center, NIH. Conducted independent research in biological rhythms, photobiology, and sleep deprivation.
1981 – 1983 Fellowship: Psychopharmacology, National Institute of Mental Health, Bethesda, MD
1979 – 1981 Residency: Psychiatry, UCLA Neuropsychiatric Institute, Los Angeles, CA
1978 – 1979 Internship: Psychiatry, UCLA Neuropsychiatric Institute, Los Angeles, CA
1978 MD, Rush Medical College, Chicago, IL
1974 B.A. Psychology, Suma Cum Laude, SUNY at Buffalo, Buffalo, NY
Licensure and Certifications:
02-28-2005 DEA License# AS9033983
Diplomat: American Society of Addiction Medicine, 2000
Honor: 1978 – Phi Beta Kappa
1. Schauf CL, Davis FA, Sack DA, Reed BT, Kesler RL: Neuroelectric blocking factors in human and sera evaluated using the isolated frog spinal chord. Journal of Neurology, Neurosurgery, and Psychiatry, 39: 680-685, 1976.
4. Rosenthal NE, Sack DA, Wehr TA: Seasonal Variation in affective disorders, in Wehr TA, Goodwin FK (eds.), Biological Rhythms in Psychiatry, Boxwood Press, Pacific Grove, California, 1983, pp. 185-201.
5. Rosenthal NE, Sack DA, Gillin JC, Lewy AJ, Goodwin FK, Davenport Y, Newsome DA, Wehr TA: Seasonal affective disorder: A description of the syndrome and preliminary findings with light therapy. Archives of General Psychiatry, 41: 72-80, 1984.
10. James SP, Wehr TA, Sack DA, Parry BL, Rosenthal NE: Evening light treatment of seasonal affective disorder. British Journal of Psychiatry, 147: 424-428, 1985.
12. Golden RN, James SP, Sherer MA, Rodorfer MV, Sack DA, Potter WZ: Psychosis associated with bupropion treatment. American Journal of Psychiatry, Dec. 1985
13. Rosenthal NE, Sack DA, Wehr TA: Seasonal effects on mood: The role of light in Adelman G(ed.), Encyclopedia of Neuroscience, Birkhauser, Boston.
15. Wehr TA, Sack DA, Parry BL, Rosenthal NE: The role of biological rhythms in the biology and treatment of insomnia and depression, in Brodie HKH, Berger PA (eds.), The American Handbook of Psychiatry.
16. Rosenthal NE, Sack DA, Jacobsen FM, James SP, Parry BL, Arendt J, Tamarkin L, Wehr TA: The role of melatonin in seasonal affective disorder. Journal of Neural Transmission.
17. James SP, Wehr TA, Sack DA, Rosenthal NE, Mendelson WB: Experimental modalities in the treatment of seasonal and non-seasonal affective disorder. Proceedings of the World Congress of Biological Psychiatry.
19. Rosenthal NE, Sack DA, Jacobsen FM, Parry BL, James SP, Tamarkin L, Arendt J, Wehr TA: Consensus and controversy in seasonal affective disorder and phototherapy. Proceedings of the World Congress of Biological Psychiatry.
20. Sack DA, James SP, Rosenthal NE, Wehr TA: Partial sleep deprivation and phase advance therapy for depression. Proceedings of the World Congress of Biological Psychiatry.
23. Wehr TA, Jacobsen FM, Sack DA, Arendt J, Tamarkin L, Rosenthal NE: Phototherapy of seasonal affective disorder. Time and day suppression of melatonin are not critical for antidepressant effects. Arch Gen Psychiatry Sept. 1986.
26. Wehr TA, Sack DA: The relevance of sleep research to affective illness. In Sleep, 1986, Koella WP, Obal F, Schula H, Visser P, eds.
27. Wehr TA, Sack DA: Jacobsen F, Tamarkin L, Arendt J, Rosenthal NE: Timing of phototherapy and its effect on melatonin secretion are not critical for its antidepressant effect in seasonal affective disorder. Archives of General Psychiatry, 43: 870-875.
28. Wehr TA, Sack DA, Rosenthal NE: Sleep and biological rhythms in bipolar illness, in Goodwin FK, Jamison K (eds.): Bipolar Disorders, in Hales RE, Frances AJ (eds.): American Psychiatric Association Press, Washington, D.C.
29. Sack DA, Wehr TA. Circadian rhythms in psychiatry. In Depression and Mania: A Comprehensive Textbook, Georgotas A, Concro R (eds.), Elsevier Science Publishing Co., New York.
30. Jacobsen FM, Wehr TA, Sack DA, James SP, Parry BL, Rosenthal NE: Seasonal affective disorder in the workplace: implications for public health. American Journal of Public Health, 77: 57-60, 1987.
32. Sack DA, Rosenthal NE, Parry BA, Wehr TA: Biological Rhythms in Psychiatry. In: Psychopharmacology. A second generation of progress.
34. James SP, Golden RN, Sack DA: Vitamin B12 deficiency and the dexamethasone test. Journal of Nervous and Mental Diseases, 174: 560-561, 1986.
35. Wehr TA, Sack DA, Rosenthal NE, Goodwin FK: Sleep and biological rhythms in bipolar disorder, Annual Review, Volume 6, American Psychiatric Association, Washington, D.C., 1986.
38. Wehr TA, Sack DA, Rosenthal NE: Reverse seasonal affective disorder with spring-summer depression and fall-winter hypomania: possible relationship to environmental
41. Sack DA, James SP, Rosenthal NE, Wehr TA: Deficient nocturnal TSH during sleep and sleep deprivation in rapid-cycling manic-depressives. Psychiatry Research, in press.
42. Sack DA, James SP, Doran AR, Sherer MA, Linnoila M, Wehr TA: The diurnal variation in plasma HVA persist by the variation in MHPG is abolished under constant conditions. Archives of General Psychiatry, in press.
43. Jacobsen FM, Sack DA, Wehr TA, Rogers S, Rosenthal NE: Neuroendocrine responses to 5-hydroxytryptopha in seasonal affective disorder. Archives of General Psychiatry, in press.
47. Sack DA, Rosenthal NE, Wehr TA: Biological rhythms in psychiatry, in Psychopharmacology: The Third Generation of Progress, Meltzer HY, editor, Raven Press, NY, 1987.
53. Rosenthal NE, Skwerer RG, Sack DA, Duncan CC, Jacobsen FM, Tamarkin L, Wehr TA: Biological effects of morning-plus-evening bright light treatment of seasonal affective disorder. Psychopharmacol Bull, 1987.
55. Kasper S, Sack DA, Wehr TA, Kick H, Voll G, Vieira A: Nocturnal TSH and prolactin secretion during sleep deprivation and prediction of antidepressant response in patients with major depression. Biol Psychiatry, Oct. 1988
58. Souetre E, Salvati E, Wehr TA, Sack DA, Krebs B, Darcourt G: Twenty-four-hour profiles of body temperature and plasma TSH in bipolar patients during depression and during remission and in normal control subjects. American Journal Psychiatry, 1988.
60. Parry BL, Mendelson WB, Duncan WC, Sack DA, Wehr TA: Longitudinal sleep EEG, temperature, and activity measurements across the menstrual cycle in patients with premenstrual depression and in age-matched controls. Psychiatry Res, 1989.
61. Sack DA: “No More Secrets, No More Shame” Understanding Sexual Abuse and Emotional Disorders. PIA Press, Washington D.C., 1990.
62. James SP, Sack DA, Rosenthal NE, Mendleson WB, Wehr TA: The effect of melatonin on polygraphically monitored sleep. Neuropsychopharmacology. 1990 Feb;3(1):19-23.
63. Wolkowitz OM, Kramer JH, Reus VI, Costa MM, Yaffe K, Walton P, Raskind M, Peskind E, Newhouse P, Sack D, De Souza E, Sadowsky C, Roberts E; DHEA-Alzheimer’s Disease Collaborative Research. Neurology. 2003 Apr 8;60(7):1071-6.
Submitted for publication:
64. Rosenthal NE, Sack DA, Carpenter CJ, Van Sant D, James SP, Wehr TA: The Weekly Mood Inventory: A self-rating scale for the longitudinal evaluation of seasonal affective disorder (SAD).
65. Rosenthal NE, Carpenter CJ, Sack DA, Jacobsen FM, James SP, Wehr TA: The placebo effect and other methodological issues in phototherapy studies of seasonal affective disorder.
Many my publications on https://www.researchgate.net/scientific-contributions/D-A-Sack-61352933
Many my publications on https://pubmed.ncbi.nlm.nih.gov/?term=Sack+DA&cauthor_id=3865248
Many my publications on https://www.psychologytoday.com/us/contributors/david-sack-md
My book “No More Secrets, No More Shame” Understanding Sexual Abuse and Emotional Disorders” on Amazon https://www.amazon.com/More-Secrets-Shame-Understanding-Emotional/dp/0929162161